Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Lorent

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Infection and Immunity|July 4, 2018
The Protozoan Parasite Toxoplasma gondii Selectively Reprograms the Host Cell TranslatomeLouis-Philippe Leroux, Julie Lorent, Tyson E Graber, et al.
Nucleic Acids Research|October 26, 2017
Polysome-profiling in small tissue samplesShuo Liang, Hermano Martins Bellato, Julie Lorent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2011
Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986Maria De Santis, Joaquim Bellmunt, Graham Mead, et al.
Frontiers in Immunology|April 17, 2023
Analysis of human lung mast cells by single cell RNA sequencingElin Rönnberg, Avinash Ravindran, Luca Mazzurana, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 2, 2018
eIF4E-Binding Proteins 1 and 2 Limit Macrophage Anti-Inflammatory Responses through Translational Repression of IL-10 and Cyclooxygenase-2Mirtha William, Louis-Philippe Leroux, Visnu Chaparro, et al.
British Journal of Cancer|January 26, 2018
Immune gene expression and response to chemotherapy in advanced breast cancerTheodoros Foukakis, John Lövrot, Alexios Matikas, et al.
EMBO Molecular Medicine|July 26, 2024
Dantrolene corrects cellular disease features of Darier disease and may be a novel treatmentMatthew Hunt, Nuoqi Wang, Naricha Pupinyo, et al.
Nature Communications|August 11, 2019
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancerTânia D F Costa, Ting Zhuang, Julie Lorent, et al.
The EMBO Journal|September 27, 2019
Translational offsetting as a mode of estrogen receptor α-dependent regulation of gene expressionJulie Lorent, Eric P Kusnadi, Vincent van Hoef, et al.
Nature Communications|March 2, 2022
Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAF<sup>V600</sup> melanomaLorey K Smith, Tiffany Parmenter, Margarete Kleinschmidt, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Infection and Immunity|July 4, 2018
The Protozoan Parasite Toxoplasma gondii Selectively Reprograms the Host Cell TranslatomeLouis-Philippe Leroux, Julie Lorent, Tyson E Graber, et al.
Nucleic Acids Research|October 26, 2017
Polysome-profiling in small tissue samplesShuo Liang, Hermano Martins Bellato, Julie Lorent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2011
Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986Maria De Santis, Joaquim Bellmunt, Graham Mead, et al.
Frontiers in Immunology|April 17, 2023
Analysis of human lung mast cells by single cell RNA sequencingElin Rönnberg, Avinash Ravindran, Luca Mazzurana, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 2, 2018
eIF4E-Binding Proteins 1 and 2 Limit Macrophage Anti-Inflammatory Responses through Translational Repression of IL-10 and Cyclooxygenase-2Mirtha William, Louis-Philippe Leroux, Visnu Chaparro, et al.
British Journal of Cancer|January 26, 2018
Immune gene expression and response to chemotherapy in advanced breast cancerTheodoros Foukakis, John Lövrot, Alexios Matikas, et al.
EMBO Molecular Medicine|July 26, 2024
Dantrolene corrects cellular disease features of Darier disease and may be a novel treatmentMatthew Hunt, Nuoqi Wang, Naricha Pupinyo, et al.
Nature Communications|August 11, 2019
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancerTânia D F Costa, Ting Zhuang, Julie Lorent, et al.
The EMBO Journal|September 27, 2019
Translational offsetting as a mode of estrogen receptor α-dependent regulation of gene expressionJulie Lorent, Eric P Kusnadi, Vincent van Hoef, et al.
Nature Communications|March 2, 2022
Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAF<sup>V600</sup> melanomaLorey K Smith, Tiffany Parmenter, Margarete Kleinschmidt, et al.
Pageof 2